Amphotericin B and Flucytosine Combination for Severe Cryptococcosis
Author Information
Author(s): Dromer Françoise, Bernede-Bauduin Claire, Guillemot Didier, Lortholary Olivier
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
What are the optimal therapeutic strategies for severe cryptococcosis?
Conclusion
Induction therapy with amphotericin B and flucytosine for at least 14 days is recommended for patients with high fungal burden.
Supporting Evidence
- Combination therapy reduced treatment failure at 2 weeks compared to other regimens.
- High serum antigen titer was associated with treatment failure.
- Patients with meningoencephalitis had better outcomes with the combination therapy.
Takeaway
This study found that a combination of two medicines works better for treating a serious fungal infection in the brain than using just one medicine.
Methodology
The study analyzed data from 208 patients with culture-proven cryptococcosis treated in French hospitals, focusing on treatment outcomes at 2 weeks and 3 months.
Potential Biases
The observational nature of the study may introduce biases related to treatment choices.
Limitations
The study design may not provide equal figures in each treatment group, which could influence significance.
Participant Demographics
Majority were HIV-positive male patients with meningoencephalitis.
Statistical Information
P-Value
p<0.001
Confidence Interval
OR [95%CI] = 4.43 [1.21–16.23], p = 0.025
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website